Abstract
Acta PaediatricaVolume 97, Issue s457 p. 97-105 MUCOPOLYSACCHARIDOSIS DISORDERS First published: 13 March 2008 https://doi.org/10.1111/j.1651-2227.2008.00657_1.xCitations: 1 The licensed dosage regimen for idursulfase (Elaprase®; Shire HGT, Danderyd, Sweden) is 0.5 mg/kg body weight every week. Shire HGT does not endorse the use of doses other than that stated in the Summary of Product Characteristics. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume97, Issues457Special Issue: Natural course, CNS pathophysiology and next targetsApril 2008Pages 97-105 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
